SCIENCE GROUP PLC Logo

SCIENCE GROUP PLC

International science & tech consultancy providing advisory, R&D, and product development.

SAG | IL

Overview

Corporate Details

ISIN(s):
GB00B39GTJ17
LEI:
2138009OJQT79BDB3E93
Country:
United Kingdom
Address:
HARSTON MILL ROYSTON ROAD, CB22 7GG CAMBRIDGE
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Science Group PLC is an international science, engineering, and technology (SET) consultancy. The company provides a range of services including independent advisory, outsourced research and development, regulatory compliance, and product development. It supports a global client base across diverse vertical markets, including medical, defence, industrial, consumer, and food & beverage. Operating through dedicated R&D innovation centers in Europe and North America, Science Group assists organizations in addressing complex scientific and technological challenges from concept through to market deployment.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-09 08:00
Transaction in Own Shares
Transaction in Own Shares
English 12.1 KB
2025-10-07 13:00
Share Issue/Capital Change
Treasury Shares Issued
English 10.7 KB
2025-10-07 08:00
Transaction in Own Shares
Transaction in Own Shares
English 12.1 KB
2025-10-03 08:00
Transaction in Own Shares
Transaction in Own Shares
English 12.1 KB
2025-10-02 08:00
Transaction in Own Shares
Transaction in Own Shares
English 12.1 KB
2025-10-01 08:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 9.4 KB
2025-09-29 13:00
Share Issue/Capital Change
Treasury shares issued
English 10.7 KB
2025-09-19 08:00
Transaction in Own Shares
Transaction in Own Shares
English 12.5 KB
2025-09-17 08:00
Transaction in Own Shares
Transaction in Own Shares
English 12.2 KB
2025-09-15 08:00
Transaction in Own Shares
Transaction in Own Shares
English 12.3 KB
2025-09-10 08:00
Transaction in Own Shares
Transaction in Own Shares
English 12.2 KB
2025-09-09 08:00
Transaction in Own Shares
Transaction in Own Shares
English 12.2 KB
2025-09-08 08:00
Transaction in Own Shares
Transaction in Own Shares
English 12.2 KB
2025-09-02 15:20
Major Shareholding Notification
Holding(s) in Company
English 53.2 KB
2025-09-02 08:00
Transaction in Own Shares
Transaction in Own Shares
English 12.2 KB

Automate Your Workflow. Get a real-time feed of all SCIENCE GROUP PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SCIENCE GROUP PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Medivir Logo
Clinical-stage pharma firm developing tumor-directed therapies for high-need cancer patients.
Sweden MVIR
Sweden MBOLIC
Milton Essex Spolka Akcyjna Logo
Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.
Poland MTN
Molecular Partners AG Logo
Pioneering DARPin protein drugs for complex diseases in oncology and virology.
Switzerland MOLN
MorphoSys AG Logo
Biopharma company creating antibody therapies for oncology, with a focus on blood cancers.
Germany MOR
Mycodern Spolka Akcyjna Logo Poland MCD
N4 PHARMA PLC Logo
Developing a nanoparticle delivery system for advanced gene and vaccine therapies.
United Kingdom N4P
NextGen Biomed Ltd. Logo
R&D of biotech medical devices for diabetes care and topical skin treatments.
Israel NXGN
Nicox S.A. Logo
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France COX
ONCIMMUNE HOLDINGS PLC Logo
Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.
United Kingdom ONC

Talk to a Data Expert

Have a question? We'll get back to you promptly.